The opportunity associated with the pharmaceutical polymers / medical polymers market is projected to grow at a CAGR of over 7% till 2035, claims Roots Analysis

The opportunity associated with the pharmaceutical polymers / medical polymers market is projected to grow at a CAGR of over 7% till 2035, claims Roots Analysis

PR Newswire

LONDON, Sept. 5, 2023

Pharmaceutical polymers have emerged as one of the versatile materials in the healthcare community owing to their various benefits, including relatively lower weight, increased durability, better biocompatibility, inertness to chemicals and longer fatigue resistance

LONDON, Sept. 5, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "Pharmaceutical Polymers / Medical Polymers Market, 2023 – 2035"" report to its list of offerings.

Roots_Analysis_Logo

Polymers have been employed in various fields, such as automotive, agriculture, construction, electronics, medical and textile. Specifically, in the pharmaceutical / medical sector, they find application as excipients in medicinal formulations, medical device components and packaging material, for dosage forms. Further, various stakeholders have developed innovative pharmaceutical / medical polymers, such as biodegradable polymers, stimuli-responsive polymers, shape memory polymers and self-healing polymers.

To order this 220+ page report, which features 65+ figures and 90+ tables, please visit our report on Medical Polymers Market

Key Market Insights

145+ companies claim to manufacture pharmaceutical polymers / medical polymers, globally

Around 40% of the industry stakeholders are based in Asia-Pacific, followed by those having headquarters in Europe (34%). In addition, majority of the companies produce amino-based pharmaceutical / medical polymers, followed by those manufacturing polysaccharide-based polymers. It is worth highlighting that 60% of the players manufacture synthetic pharmaceutical polymers / medical polymers.

Partnership activity was observed to grow at a CAGR of around 15%, between 2019 and 2022

Majority of the agreements related to pharmaceutical / medical polymers were observed to be focused on product development, representing nearly 30% of the total partnerships. Further, most of the intercontinental, as well as intracontinental deals have been inked by players based in Europe.

DELT framework assists pharmaceutical polymer / medical polymer manufacturers in evaluating their current capabilities to operate within the industry

This framework takes into consideration the external forces (demographical) and internal forces (environmental, legal and technological) that may affect the strategic business of a company. In addition, it provides a consolidated view on the likely threats and opportunities within the pharmaceutical polymers / medical polymers domain.

North America and Europe are anticipated to capture around 75% of the market share, by 2035

The market in Asia-Pacific is likely to grow at a relatively faster pace (9.2%), in the long term. Currently, majority share (65%) of the overall pharmaceutical polymers / medical polymers market is captured by thermoplastic polymers; this trend is unlikely to change in the foreseen future as well. Further, by 2035, more than 45% of the market share is likely to be captured by pharmaceutical polymers / medical polymers intended for applications in medical devices.

To request a sample copy / brochure of this report, please visit Get Free Report Sample 

Key Questions Answered

The financial opportunity within the pharmaceutical polymers / medical polymers market has been analyzed across the following segments:

The report also features inputs from eminent industry stakeholders, according to whom, the continuously rising demand for novel polymeric medical devices, coupled to the ongoing technological advancements in this domain is likely to drive the growth of the overall pharmaceutical polymers / medical polymers market, in the foreseen future. The report includes detailed transcripts of discussions held with the following experts:

The research includes profiles of key players (listed below) engaged in this domain; each profile features a brief overview of the company, details related to its financial performance (if available), pharmaceutical polymers / medical polymers focused portfolio, recent developments and an informed future outlook.

For additional details, please visit 

https://www.rootsanalysis.com/reports/medical-polymers-market.html or email sales@rootsanalysis.com 

You may also be interested in the following titles:

  1. Global Bioreactors and Fermenters Market: Industry Trends and Global Forecasts, 2023-2035
  2. Non-Viral Transfection Reagents and Systems Market (2nd Edition) Market: Industry Trends and Global Forecasts, 2023-2035
  3. Modular Manufacturing Facilities Market in Pharmaceutical and Biotechnology Market: Industry Trends and Global Forecasts, 2023-2035
  4. Long-Acting Drug Delivery Technologies and Services Market: Industry Trends and Global Forecasts, 2023-2035
  5. 4D Bioprinting Market: Industry Trends and Global Forecasts, 2023-2035
  6. Non-Viral / Intracellular Drug Delivery Systems Market: Industry Trends and Global Forecasts, 2023-2035
  7. Dental 3D Printing Market: Industry Trends and Global Forecasts, 2023-2035

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/the-opportunity-associated-with-the-pharmaceutical-polymers--medical-polymers-market-is-projected-to-grow-at-a-cagr-of-over-7-till-2035-claims-roots-analysis-301916978.html

Voltar noticias em Inglês